Form 4 for ANIX Anixa Biosciences Inc
Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-07 · accession 0001493152-22-000640 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-07 | 2022-01-07 | ANIX | KUMAR AMIT | CEO, Dir | P - Purchase | $3.00 | +20.0K | 314.0K | +7% | +$60.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | P | A | 20,000 | $3.00 | 314,000 | D | — | — |